Below are selected publications from 2007; please check here to cite the use of Glide

• •  Kim, Y.A.; Sharon, A.; Chu, C.K.; Rais, R.H.; Al Safarjalani, O.N.; Naguib, F.N.M.; el Kouni, M.H., "Synthesis, biological evaluation and molecular modeling studies of N-6-benzyladenosine analogues as potential anti-toxoplasma agents," Biochem. Pharmacol., 2007, 73, 1558-1572
• •  Siddiquee, K.; Zhang, S.; Guida, W.C.; Blaskovich, M.A.; Greedy, B.; Lawrence, H.R.; Yip, M.L.; Jove, R.; McLaughlin, M.M.; Lawrence, N.J.; Sebti, S.M.; Turkson J., "Selective chemical probe inhibitor of Stat3, identified through structure-based virtual screening, induces antitumor activity," Proc. Natl. Acad. Sci., 2007, 104, 7391–7396
• •  Zhou, Z.; Felts, A. K.; Friesner, R. A.; Levy, R. M., "Comparative Performance of Several Flexible Docking Programs and Scoring Functions: Enrichment Studies for a Diverse Set of Pharmaceutically Relevant Targets," J. Chem. Inf. Model, 2007, 47, 1599–1608
• •  Englebienne, P.; Fiaux, H.; Kuntz, D. A.; Corbeil, C. R.; Gerber-Lemaire, S.; Rose, D. R.; Moitessier, N., "Evaluation of docking programs for predicting binding of Golgi alpha-mannosidase II inhibitors: A comparison with crystallography," Proteins: Structure, Function, and Bioinformatics, 2007, 69, 160–176
• •  Tripathy, R.; Ghose, A.; Singh, J.; Bacon, E. R.; Angeles, T. S.; Yang, S. X.; Albom, M. S.; Aimone, L. S.; Herman, J. L.; Mallamo, J. P., "1,2,3-Thiadiazole substituted pyrazolones as potent KDR/VEGFR-2 kinase inhibitors," Bioorg. Med. Chem. Lett., 2007, 17, 1793–1798

• ö indicates papers (co)authored by Schrödinger scientist(s).